{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:44:54Z","timestamp":1791575094883,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,3,28]],"date-time":"2013-03-28T00:00:00Z","timestamp":1364428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,3,28]],"date-time":"2013-03-28T00:00:00Z","timestamp":1364428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s00432-013-1412-6","type":"journal-article","created":{"date-parts":[[2013,3,27]],"date-time":"2013-03-27T12:25:23Z","timestamp":1364387123000},"page":"1105-1115","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["MG132-mediated inhibition of the ubiquitin\u2013proteasome pathway ameliorates cancer cachexia"],"prefix":"10.1007","volume":"139","author":[{"given":"Liuping","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangbin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,28]]},"reference":[{"issue":"1","key":"1412_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jmb.2008.08.087","volume":"384","author":"V Adams","year":"2008","unstructured":"Adams V et al (2008) Induction of MuRF1 is essential for TNF-alpha-induced loss of muscle function in mice. J Mol Biol 384(1):48\u201359","journal-title":"J Mol Biol"},{"issue":"11","key":"1412_CR2","doi-asserted-by":"publisher","first-page":"5531","DOI":"10.1158\/0008-5472.CAN-06-4585","volume":"67","author":"T Agustsson","year":"2007","unstructured":"Agustsson T et al (2007) Mechanism of increased lipolysis in cancer cachexia. Cancer Res 67(11):5531\u20135537","journal-title":"Cancer Res"},{"issue":"7","key":"1412_CR38","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1002\/art.27492","volume":"62","author":"AS Ahmed","year":"2010","unstructured":"Ahmed AS et al (2010) Attenuation of pain and inflammation in adjuvant-induced arthritis by the proteasome inhibitor MG132. Arthritis Rheum 62(7):2160\u20132169","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1412_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/(SICI)1098-1128(199905)19:3<223::AID-MED3>3.0.CO;2-N","volume":"19","author":"JM Argiles","year":"1999","unstructured":"Argiles JM, Lopez-Soriano FJ (1999) The role of cytokines in cancer cachexia. Med Res Rev 19(3):223\u2013248","journal-title":"Med Res Rev"},{"issue":"5547","key":"1412_CR4","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1126\/science.1065874","volume":"294","author":"SC Bodine","year":"2001","unstructured":"Bodine SC et al (2001) Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294(5547):1704\u20131708","journal-title":"Science"},{"issue":"2","key":"1412_CR5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cell.2004.09.027","volume":"119","author":"D Cai","year":"2004","unstructured":"Cai D et al (2004) IKKbeta\/NF-kappaB activation causes severe muscle wasting in mice. Cell 119(2):285\u2013298","journal-title":"Cell"},{"issue":"10","key":"1412_CR6","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1016\/j.biocel.2004.11.010","volume":"37","author":"PR Cao","year":"2005","unstructured":"Cao PR, Kim HJ, Lecker SH (2005) Ubiquitin-protein ligases in muscle wasting. Int J Biochem Cell Biol 37(10):2088\u20132097","journal-title":"Int J Biochem Cell Biol"},{"key":"1412_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/1471-2474-12-185","volume":"12","author":"AZ Caron","year":"2011","unstructured":"Caron AZ et al (2011) The proteasome inhibitor MG132 reduces immobilization-induced skeletal muscle atrophy in mice. BMC musculoskeletal disord 12:185","journal-title":"BMC musculoskeletal disord"},{"issue":"4","key":"1412_CR39","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/JES.0b013e3181f44f11","volume":"38","author":"JA Carson","year":"2010","unstructured":"Carson JA, Baltgalvis KA (2010) Interleukin 6 as a key regulator of muscle mass during cachexia. Exerc Sport Sci Rev 38(4):168\u2013176","journal-title":"Exerc Sport Sci Rev"},{"key":"1412_CR8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1146\/annurev-med-061509-131248","volume":"62","author":"S Dodson","year":"2011","unstructured":"Dodson S et al (2011) Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies. Annu Rev Med 62:265\u2013279","journal-title":"Annu Rev Med"},{"issue":"12","key":"1412_CR9","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1038\/sj.bjc.6604785","volume":"99","author":"J Faber","year":"2008","unstructured":"Faber J et al (2008) Beneficial immune modulatory effects of a specific nutritional combination in a murine model for cancer cachexia. Br J Cancer 99(12):2029\u20132036","journal-title":"Br J Cancer"},{"issue":"8","key":"1412_CR10","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.ejca.2008.02.033","volume":"44","author":"KC Fearon","year":"2008","unstructured":"Fearon KC (2008) Cancer cachexia: developing multimodal therapy for a multidimensional problem. Eur J Cancer 44(8):1124\u20131132","journal-title":"Eur J Cancer"},{"issue":"5","key":"1412_CR11","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K et al (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12(5):489\u2013495","journal-title":"Lancet Oncol"},{"issue":"3","key":"1412_CR40","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/MCO.0b013e32833862df","volume":"13","author":"DJ Glass","year":"2010","unstructured":"Glass DJ (2010) Signaling pathways perturbing muscle mass. Curr Opin Clin Nutr Metab Care 13(3):225\u2013229","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"25","key":"1412_CR12","doi-asserted-by":"publisher","first-page":"14440","DOI":"10.1073\/pnas.251541198","volume":"98","author":"MD Gomes","year":"2001","unstructured":"Gomes MD et al (2001) Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci USA 98(25):14440\u201314445","journal-title":"Proc Natl Acad Sci USA"},{"key":"1412_CR13","doi-asserted-by":"crossref","unstructured":"Guo N, Z. Peng (2012) MG132 a proteasome inhibitor, induces apoptosis in tumor cells. Asia-Pacific j clin oncol","DOI":"10.1111\/j.1743-7563.2012.01535.x"},{"issue":"5488","key":"1412_CR14","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1126\/science.289.5488.2363","volume":"289","author":"DC Guttridge","year":"2000","unstructured":"Guttridge DC et al (2000) NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 289(5488):2363\u20132366","journal-title":"Science"},{"issue":"12 Pt 1","key":"1412_CR15","first-page":"5910","volume":"44","author":"CP Holroyde","year":"1984","unstructured":"Holroyde CP et al (1984) Glucose metabolism in cachectic patients with colorectal cancer. Cancer Res 44(12 Pt 1):5910\u20135913","journal-title":"Cancer Res"},{"issue":"1","key":"1412_CR16","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1365-2249.2008.03872.x","volume":"156","author":"S Inoue","year":"2009","unstructured":"Inoue S et al (2009) The effect of proteasome inhibitor MG132 on experimental inflammatory bowel disease. Clin Exp Immunol 156(1):172\u2013182","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"1412_CR17","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1002\/mus.21949","volume":"43","author":"C Jamart","year":"2011","unstructured":"Jamart C et al (2011) Prevention of muscle disuse atrophy by MG132 proteasome inhibitor. Muscle Nerve 43(5):708\u2013716","journal-title":"Muscle Nerve"},{"issue":"1","key":"1412_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jss.2011.09.001","volume":"176","author":"H Jing","year":"2012","unstructured":"Jing H et al (2012) MG132 alleviates liver injury induced by intestinal ischemia\/reperfusion in rats: involvement of the AhR and NFkappaB pathways. J surg res 176(1):63\u201373","journal-title":"J surg res"},{"issue":"1","key":"1412_CR19","doi-asserted-by":"publisher","first-page":"C372","DOI":"10.1152\/ajpcell.00293.2006","volume":"292","author":"AR Judge","year":"2007","unstructured":"Judge AR et al (2007) Role for IkappaBalpha, but not c-Rel, in skeletal muscle atrophy. Am J Physiol Cell Physiol 292(1):C372\u2013C382","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"1412_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/sj.gt.3300819","volume":"6","author":"I Kawamura","year":"1999","unstructured":"Kawamura I et al (1999) Intratumoral injection of oligonucleotides to the NF kappa B binding site inhibits cachexia in a mouse tumor model. Gene Ther 6(1):91\u201397","journal-title":"Gene Ther"},{"issue":"7","key":"1412_CR21","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s00109-004-0555-y","volume":"82","author":"A Kumar","year":"2004","unstructured":"Kumar A et al (2004) Nuclear factor-kappaB: its role in health and disease. J Mol Med 82(7):434\u2013448","journal-title":"J Mol Med"},{"issue":"10","key":"1412_CR22","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s00109-008-0373-8","volume":"86","author":"H Li","year":"2008","unstructured":"Li H, Malhotra S, Kumar A (2008) Nuclear factor-kappa B signaling in skeletal muscle atrophy. J Mol Med 86(10):1113\u20131126","journal-title":"J Mol Med"},{"issue":"3","key":"1412_CR23","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.taap.2011.11.018","volume":"258","author":"T Lombardo","year":"2012","unstructured":"Lombardo T et al (2012) Synergism between arsenite and proteasome inhibitor MG132 over cell death in myeloid leukemic cells U937 and the induction of low levels of intracellular superoxide anion. Toxicol Appl Pharmacol 258(3):351\u2013366","journal-title":"Toxicol Appl Pharmacol"},{"issue":"10","key":"1412_CR24","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.bcp.2011.03.009","volume":"81","author":"Y Ma","year":"2011","unstructured":"Ma Y et al (2011) MG132 treatment attenuates cardiac remodeling and dysfunction following aortic banding in rats via the NF-kappaB\/TGFbeta1 pathway. Biochem Pharmacol 81(10):1228\u20131236","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"1412_CR25","first-page":"805","volume":"22","author":"LG Melstrom","year":"2007","unstructured":"Melstrom LG et al (2007) Mechanisms of skeletal muscle degradation and its therapy in cancer cachexia. Histol Histopathol 22(7):805\u2013814","journal-title":"Histol Histopathol"},{"issue":"1\u20132","key":"1412_CR26","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ymgme.2012.07.013","volume":"107","author":"EM O\u2019Leary","year":"2012","unstructured":"O\u2019Leary EM, Igdoura SA (2012) The therapeutic potential of pharmacological chaperones and proteosomal inhibitors, Celastrol and MG132 in the treatment of sialidosis. Mol Genet Metab 107(1\u20132):173\u2013185","journal-title":"Mol Genet Metab"},{"issue":"Suppl 9","key":"1412_CR41","first-page":"251","volume":"59","author":"B Pajak","year":"2008","unstructured":"Pajak B et al (2008) Crossroads of cytokine signaling\u2013the chase to stop muscle cachexia: an official. J physiol pharmacol 59(Suppl 9):251\u2013264","journal-title":"J physiol pharmacol"},{"issue":"6","key":"1412_CR27","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.cytogfr.2006.09.006","volume":"17","author":"A Saini","year":"2006","unstructured":"Saini A, Al-Shanti N, Stewart CE (2006) Waste management\u2014cytokines, growth factors and cachexia. Cytokine Growth Factor Rev 17(6):475\u2013486","journal-title":"Cytokine Growth Factor Rev"},{"issue":"18","key":"1412_CR28","doi-asserted-by":"publisher","first-page":"10112","DOI":"10.1128\/JVI.01001-12","volume":"86","author":"M Schneider","year":"2012","unstructured":"Schneider M et al (2012) Severe acute respiratory syndrome coronavirus replication is severely impaired by MG132 due to proteasome-independent inhibition of M-calpain. J Virol 86(18):10112\u201310122","journal-title":"J Virol"},{"issue":"13","key":"1412_CR29","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.yexcr.2012.04.003","volume":"318","author":"ES Sung","year":"2012","unstructured":"Sung ES et al (2012) The proteasome inhibitor MG132 potentiates TRAIL receptor agonist-induced apoptosis by stabilizing tBid and Bik in human head and neck squamous cell carcinoma cells. Exp Cell Res 318(13):1564\u20131576","journal-title":"Exp Cell Res"},{"issue":"8","key":"1412_CR30","first-page":"2290","volume":"50","author":"Y Tanaka","year":"1990","unstructured":"Tanaka Y et al (1990) Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice. Cancer Res 50(8):2290\u20132295","journal-title":"Cancer Res"},{"issue":"2 Pt 1","key":"1412_CR31","doi-asserted-by":"crossref","first-page":"C320","DOI":"10.1152\/ajpcell.1999.277.2.C320","volume":"277","author":"D Thaloor","year":"1999","unstructured":"Thaloor D et al (1999) Systemic administration of the NF-kappaB inhibitor curcumin stimulates muscle regeneration after traumatic injury. American j physiol 277(2 Pt 1):C320\u2013C329","journal-title":"American j physiol"},{"issue":"2","key":"1412_CR32","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1152\/physrev.00016.2008","volume":"89","author":"MJ Tisdale","year":"2009","unstructured":"Tisdale MJ (2009) Mechanisms of cancer cachexia. Physiol Rev 89(2):381\u2013410","journal-title":"Physiol Rev"},{"issue":"1","key":"1412_CR33","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.canlet.2011.02.023","volume":"305","author":"H Wang","year":"2011","unstructured":"Wang H et al (2011a) Epigallocatechin-3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexia. Cancer Lett 305(1):40\u201349","journal-title":"Cancer Lett"},{"issue":"6","key":"1412_CR34","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1089\/vim.2011.0038","volume":"24","author":"Y Wang","year":"2011","unstructured":"Wang Y et al (2011b) Comparative study of the influence of proteasome inhibitor MG132 and ganciclovir on the cytomegalovirus-specific CD8(+) T-cell immune response. Viral Immunol 24(6):455\u2013461","journal-title":"Viral Immunol"},{"key":"1412_CR37","doi-asserted-by":"crossref","unstructured":"Winder SJ et al. (2011) The proteasomal inhibitor MG132 prevents muscular dystrophy in zebrafish. PLoS currents, 3: p. RRN1286","DOI":"10.1371\/currents.RRN1286"},{"issue":"6","key":"1412_CR35","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1007\/s10637-012-9804-z","volume":"30","author":"A Zanotto-Filho","year":"2012","unstructured":"Zanotto-Filho A et al (2012) Proteasome inhibitor MG132 induces selective apoptosis in glioblastoma cells through inhibition of PI3\u00a0K\/Akt and NFkappaB pathways, mitochondrial dysfunction, and activation of p38-JNK 1\/2 signaling. Invest New Drugs 30(6):2252\u20132262","journal-title":"Invest New Drugs"},{"issue":"4","key":"1412_CR36","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","volume":"142","author":"X Zhou","year":"2010","unstructured":"Zhou X et al (2010) Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell 142(4):531\u2013543","journal-title":"Cell"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-013-1412-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-013-1412-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-013-1412-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-013-1412-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:00:12Z","timestamp":1744149612000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-013-1412-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,28]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["1412"],"URL":"https:\/\/doi.org\/10.1007\/s00432-013-1412-6","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,28]]},"assertion":[{"value":"7 January 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}